Supernus Pharmaceuticals (SUPN) EBIT Growth (3y) (2014 - 2025)
Supernus Pharmaceuticals (SUPN) EBIT Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 273.62% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 3.84% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -59.82% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 4.63% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -30.05% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 54.58% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 40.17% |
| 10 | Supernus Pharmaceuticals | 2.72 Bn | 2.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -28.36% |
| Sep 30, 2025 | -240.70% |
| Jun 30, 2025 | 2.28% |
| Mar 31, 2025 | -93.22% |
| Dec 31, 2024 | 51.98% |
| Sep 30, 2024 | 7.80% |
| Jun 30, 2024 | -12.86% |
| Mar 31, 2024 | -30.82% |
| Dec 31, 2023 | -26.48% |
| Sep 30, 2023 | -47.47% |
| Mar 31, 2023 | -43.70% |
| Dec 31, 2022 | -5.60% |
| Sep 30, 2022 | -26.79% |
| Jun 30, 2022 | -35.66% |
| Mar 31, 2022 | -57.39% |
| Dec 31, 2021 | -46.51% |
| Sep 30, 2021 | -4.54% |
| Jun 30, 2021 | -1.52% |
| Mar 31, 2021 | -25.06% |
| Dec 31, 2020 | 7.78% |